| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 12 | |
| #2 | WIPO (World Intellectual Property Organization) | 10 | |
| #3 | EPO (European Patent Office) | 9 | |
| #4 | Australia | 7 | |
| #5 | Canada | 6 | |
| #6 | China | 5 | |
| #7 | Brazil | 4 | |
| #8 | Republic of Korea | 4 | |
| #9 | United Kingdom | 3 | |
| #10 | Hong Kong | 2 | |
| #11 | Israel | 2 | |
| #12 | Japan | 2 | |
| #13 | Mexico | 2 | |
| #14 | Singapore | 2 | |
| #15 | Colombia | 1 | |
| #16 | Cuba | 1 | |
| #17 | India | 1 | |
| #18 | Peru | 1 | |
| #19 | Philippines | 1 | |
| #20 | Russian Federation | 1 | |
| #21 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Agriculture |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Microorganisms | |
| #4 | Peptides | |
| #5 | Analysing materials | |
| #6 | Animal care |
| # | Name | Total Patents |
|---|---|---|
| #1 | Vander Elst Luc | 54 |
| #2 | Saint-Remy Jean-Marie | 48 |
| #3 | Carlier Vincent | 43 |
| #4 | Burkhart David | 11 |
| #5 | Luc Vander Elst | 7 |
| #6 | Jean-Marie Saint-Remy | 6 |
| #7 | Vincent Carlier | 6 |
| #8 | Saint Remy Jean Marie | 4 |
| #9 | Erak Milos | 4 |
| #10 | David Burkhart | 3 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020229703A1 | Immunogenic peptides with an oxidoreductase motif comprising a modified cysteine | |
| WO2020099352A2 | Immunogenic peptides with new oxidoreductase motifs | |
| CN110536898A | For treating the peptide and method of diabetes | |
| AU2017252192A1 | Novel immunogenic CD1d binding peptides | |
| WO2017050966A1 | Improved methods and compounds for eliminating immune responses to therapeutic agents | |
| US2016339121A1 | Animal models for evaluating pharmaceutical compounds | |
| GB201418433D0 | Novel immunogenic peptides | |
| GB201319160D0 | Methods for induction of antigen-specific regulatory t cells | |
| GB201309469D0 | Detection of CD4+ T lymphocytes | |
| CA2871541A1 | Methods for induction of antigen-specific regulatory t cells |